<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Plast Reconstr Surg Glob Open</journal-id>
<journal-id journal-id-type="iso-abbrev">Plast Reconstr Surg Glob Open</journal-id>
<journal-id journal-id-type="publisher-id">GOX</journal-id>
<journal-title-group>
<journal-title>Plastic and Reconstructive Surgery Global Open</journal-title>
</journal-title-group>
<issn pub-type="epub">2169-7574</issn>
<publisher>
<publisher-name>Wolters Kluwer Health</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32537296</article-id>
<article-id pub-id-type="pmc">7288895</article-id>
<article-id pub-id-type="art-access-id">00012</article-id>
<article-id pub-id-type="doi">10.1097/GOX.0000000000002540</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Syndromic and Systemic Diagnoses Associated With Isolated Sagittal Synostosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Davis</surname>
<given-names>Amani A.</given-names>
</name>
<degrees>BA</degrees>
<xref ref-type="aff" rid="aff1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Haredy</surname>
<given-names>Mostafa M.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2">†</xref>
<xref ref-type="aff" rid="aff3">‡</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huey</surname>
<given-names>Jennifer</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="aff1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scanga</surname>
<given-names>Hannah</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="aff1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zuccoli</surname>
<given-names>Giulio</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff4">§</xref>
<xref ref-type="aff" rid="aff5">¶</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pollack</surname>
<given-names>Ian F.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff6">‖</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tamber</surname>
<given-names>Mandeep S.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff6">‖</xref>
<xref ref-type="aff" rid="aff7">**</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Goldstein</surname>
<given-names>Jesse</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Madan-Khetarpal</surname>
<given-names>Suneeta</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff8">††</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Nischal</surname>
<given-names>Ken K.</given-names>
</name>
<degrees>MD, FRCOphth</degrees>
<xref ref-type="aff" rid="aff1">*</xref>
<xref ref-type="aff" rid="aff9">‡‡</xref>
</contrib>
<aff id="aff1">From the <label>*</label>Department of Ophthalmology, UPMC Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pa.</aff>
<aff id="aff2"><label>†</label>Department of Plastic Surgery, UPMC Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh Pa.</aff>
<aff id="aff3"><label>‡</label>Plastic Surgery Department, Cleft and Craniofacial Unit, Sohag University Hospital, Sohag, Egypt</aff>
<aff id="aff4"><label>§</label>Department of Radiology, UPMC Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pa.</aff>
<aff id="aff5"><label>¶</label>Department of Radiology, Children’s Hospital of Philadelphia, Philadelphia, Pa.</aff>
<aff id="aff6"><label>‖</label>Department of Neurosurgery, UPMC Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pa.</aff>
<aff id="aff7"><label>†</label>†Department of Medical Genetics, UPMC Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pa.</aff>
<aff id="aff8"><label>*</label>*UBC Department of Surgery, Division of Neurosurgery, BC Children’s Hospital, Vancouver, British Columbia</aff>
<aff id="aff9"><label>‡</label>‡UPMC Eye center, University of Pittsburgh Medical Center, Pittsburgh, Pa.</aff>
</contrib-group>
<author-notes>
<corresp id="c1">Ken K. Nischal, MD, FRCOphth, UPMC Eye Center, Children’s Hospital of Pittsburgh of UPMC, 4401 Penn Ave., Pittsburgh, PA 15224, E-mail: <email xlink:href="nischalkk@upmc.edu">nischalkk@upmc.edu</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>12</month>
<year>2019</year>
</pub-date>
<volume>7</volume>
<issue>12</issue>
<elocation-id>e2540</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>8</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>3</day>
<month>10</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND)</ext-link>, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.</license-p>
</license>
</permissions>
<self-uri xlink:href="gox-7-e2540.pdf" xlink:type="simple"></self-uri>
<abstract>
<title>Background:</title>
<p>Reports of systemic associations in patients with Isolated Sagittal Synostosis (ISS) are sparse. Craniofacial surgeons, and other providers, should be aware that a significant proportion of patients with ISS may have syndromic or systemic involvement. This study investigates the incidence of systemic disease and syndromic diagnosis in a cohort of patients presenting with ISS (ie, patients with sagittal synostosis without other sutural involvement).</p>
<sec>
<title>Methods:</title>
<p>This study consists of a retrospective review of patients diagnosed with ISS between 2007 and 2017 at a single institution. Patients were divided according to onset (early &lt;1 year, late &gt;1 year) of ISS. Patient notes were examined for congenital anomalies, systemic conditions, and molecular testing. Only patients with isolated sagittal fusion—meaning, patients with sagittal synostosis and no other sutural involvement—were included.</p>
</sec>
<sec>
<title>Results:</title>
<p>Three hundred seventy-seven patients met the inclusion criteria: systemic conditions were identified in 188/377 (50%) of them. One hundred sixty-one patients with early onset (Group A), and 216 patients with late onset ISS (Group B) were identified. Systemic involvement was identified in 38% of Group A and 60% of Group B, which was statistically significant (<italic>P</italic> &lt; 0.001). Forty-eight of 377 (13%) of patients had a syndromic diagnosis, and 79% of these were confirmed via genetic testing. Thirty-five percent of patients were diagnosed with central nervous system anomalies and 16% had craniofacial anomalies.</p>
</sec>
<sec>
<title>Conclusions:</title>
<p>Nearly 50% of the patients initially diagnosed with ISS were found to have some form of systemic involvement. This supports affording full pediatric and genetic evaluation with molecular testing to these children.</p>
</sec>
</abstract>
<custom-meta-group>
<custom-meta>
<meta-name>OPEN-ACCESS</meta-name>
<meta-value>TRUE</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>INTRODUCTION</title>
<p>Craniosynostosis (CS) is the premature fusion of one or more cranial sutures and may be syndromic or nonsyndromic.<sup><xref ref-type="bibr" rid="R1">1</xref></sup> CS occurs one in every 2,000–2,500 live births.<sup><xref ref-type="bibr" rid="R2">2</xref></sup> The gold standard for diagnosis is a 3D-CT scan.<sup><xref ref-type="bibr" rid="R3">3</xref></sup> Sagittal CS is the premature fusion of the sagittal cranial suture, resulting in a lengthened cranium in the anterior–posterior direction with stunted growth in the parietal and temporal regions.<sup><xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R5">5</xref></sup> Patients with Isolated Sagittal Synostosis (ISS) have no other sutural involvement, and account for half of all cases of CS.<sup><xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R7">7</xref></sup> Reports of systemic associations in patients with ISS are sparse.<sup><xref ref-type="bibr" rid="R8">8</xref>–<xref ref-type="bibr" rid="R16">16</xref></sup> This study investigates the incidence of systemic disease and syndromic diagnosis in a cohort of patients presenting with ISS. Our investigation was inclusive of previously identified (such as Rickets and Noonan syndrome), as well as previously unidentified or underreported (such as seizures, Stickler and Waardenburg) syndromes and systemic findings in patients with ISS.</p>
</sec>
<sec sec-type="methods">
<title>METHODS</title>
<p>Patients diagnosed with ISS were identified through perusal of clinical databases (pediatric ophthalmology, radiology, neurosurgery, and cleft craniofacial departments) for the years 2007–2017 at a single institution. Our children’s hospital is a major referral center for craniofacial anomalies. All patients included in the study obtained a CT diagnosis of CS. Each patient was then evaluated by the cleft-craniofacial team. Only patients with isolated sagittal fusion—meaning, patients with sagittal synostosis and no other sutural involvement—were included. Patients who developed ISS after a shunting procedure for hydrocephalus or had multisutural CS were excluded. Patients were then divided according to their age at diagnosis of ISS. Group A: early onset (cases diagnosed at ≤ 1 year of age), Group B: late onset (cases diagnosed after 1 year of age). Patient notes were examined for the following data sets: date of birth, age of presentation, age at last follow-up, other congenital anomalies, systemic conditions, syndromic diagnosis, and molecular testing results. The genetic testing protocol at our institution includes SNP, exome, and specific panel testing. Exome testing can be employed as first; second; or third tier testing. First tier testing also includes SNP arrays (combo chip for complete micro arrays with SNP arrays) to determine copy number and copy neutral variation. If phenotype is very clear then a panel is recommended (eg, Noonan or CTD like Loeys-Dietz). Different services at our institution simultaneously phenotype during consultations and management; which includes imaging and biochemical testing. Finally, clinical testing for genetics may be determined by the family history. Statement of IRB approval:IRB#:REN17110211/PRO16110394.</p>
<p>All systemic diagnoses were initially included. Once all were gathered, nonspecific findings or those that were not causative or etiologically related were excluded, such as cerebral palsy, Gastroesophageal reflux disease, Moyamoya disease, caudal regression, G6PD deficiency, congenital nonstationary night blindness, Gaucher, and VACTERL syndromes. Patient information regarding genetic diagnoses was verified by a genetic counselor. IRB approval was obtained before the beginning of this research project. Statistics were conducted using SPSS, and a chi-square test was run to determine a significant difference in the incidence of systemic involvement between Group A and B. None of the authors has a financial interest in any of the products, devices, or drugs mentioned in this article.</p>
</sec>
<sec sec-type="results">
<title>RESULTS</title>
<p>Three hundred seventy-seven patients with ISS were identified. Systemic conditions were identified in 188/377 of the total cohort. Thirty-eight percent of early onset patients had systemic involvement, and 60% of late onset patients had systemic involvement. Within the 188 patients with systemic involvement, 48 (25%) had an identifiable syndrome. Of these 48, 42 underwent molecular testing. In total, 38/48 syndromes were confirmed via genetic testing (79%). The complete range of syndromic and molecular diagnoses is shown in Table <xref ref-type="table" rid="T1">1</xref>.</p>
<table-wrap id="T1" position="float">
<label>Table 1.</label>
<caption>
<p>Syndromes and Chromosomal Abnormalities in Total ISS Cohort</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Type</th>
<th align="center" colspan="1" rowspan="1"></th>
<th align="center" colspan="1" rowspan="1">Sex (M/F)</th>
<th align="center" colspan="1" rowspan="1">Genetic Testing Results</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Neuro/neurocutaneous: total: 2</td>
<td align="left" colspan="1" rowspan="1">Linear nevus sebaceous syndrome: 1 total</td>
<td align="center" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">No testing</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Acrocallosal syndrome: 1 total</td>
<td align="center" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">KIF7: c.2364delC (p.Arg789fs) and c.2593-3C&gt;G</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">RASopathies: total: 8</td>
<td align="left" colspan="1" rowspan="1">Cardiofaciocutaneous syndrome: 2 total</td>
<td align="center" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">BRAF: c.1741A&gt;G (p.Asn581Asp)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">BRAF: c.1497A&gt;C(p.K499N)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Noonan syndrome: 6 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">KRAS: c.40G&gt;A (pg.Val14Ile)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">PTPN 11: c.188A&gt;G, (p.Tyr63Cys)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">BRAF: c.735A&gt;T (p.Leu245Phe)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">Negative results</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">Negative results</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">c.1096dup(p.T367fs) mutation in the FANCL gene</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Metabolic disorders: 3</td>
<td align="left" colspan="1" rowspan="1">Autosomal recessive rickets: 1 total</td>
<td align="center" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">DMP1: c.403C&gt;T (p.Gly135Term); DMP1 8.15 kb deletion</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">X-linked rickets: 2 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">X-linked rickets</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">X-linked rickets</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Connective tissue disorders: total: 4</td>
<td align="left" colspan="1" rowspan="1">Loeys-Dietz syndrome: 1 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">TGFBR1: c.997G&gt;T; (p.ASp333Tyr)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Type II Stickler syndrome: 1 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">COLIIA1: IVS37 + 5G&gt;A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Multiple exotoses Type I: 1 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">Confirmed EXT1 mutation, maternally inherited</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Williams syndrome: 1 total</td>
<td align="center" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">No testing</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Craniofacial disorders: total: 3</td>
<td align="left" colspan="1" rowspan="1">Pfeiffer syndrome: 1 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">No testing</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Craniofrontonasal dysplasia: 1 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">EFNB1: c.466C&gt;T (p.Arg156Cys)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Saethre-Chozten suspect: 1 total</td>
<td align="center" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">Negative results</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Single gene mutations: total: 4</td>
<td align="left" colspan="1" rowspan="1">KCNT1 mutation; mitochondrial disorder, (complex IV deficiency): 1 total</td>
<td align="center" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">KCNT1: c.2683T&gt;C, (p.Tyr895His)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">FLNB and ADAMTS10 mutations: 1 total</td>
<td align="center" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">FLNB: c.735_736dupGG (p.A246fs); ADAMTS10: c.1265C&gt;T(p.A422V)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">MESP2 mutation: 1 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">MESP2: a c.813-814del mutation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Connexin 26 (GJB2): 1 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">Connexin 26 (GJB2): c.35delG, 167delT</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Skeletal disorders: total: 2</td>
<td align="left" colspan="1" rowspan="1">Osteogenesis imperfecta type V: 1 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">No testing</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Gorham syndrome: 1 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">Negative results</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Pigmentary disorders: total: 1</td>
<td align="left" colspan="1" rowspan="1">Waardenburg syndrome: 1 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">PAX3: p.R26X</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Chromosome (micro array) syndromes: total: 4</td>
<td align="left" colspan="1" rowspan="1">DiGeorge syndrome: 1 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">22q11.2 deletion</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Turner syndrome: 1 total</td>
<td align="center" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">45X</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Kleefestra syndrome: 1 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">9q34.3 deletion: 279.6Kb deletion including EHMT1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Cohen syndrome (suspect): 1 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">2q14.3 deletion and 16p13.3 deletion of 158 kb. Contains part of the RBFOX1(A2BP1) gene</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Other Total: 2</td>
<td align="left" colspan="1" rowspan="1">Ectodermal dysplasia: 1 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">Negative results</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Heterotaxy syndrome: 1 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">NODAL: c.904C&gt;T</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Chromosomal abnormalities: total: 15</td>
<td align="left" colspan="1" rowspan="1">Chromosomal translocation syndrome of 5q and 7q: 1 total</td>
<td align="center" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">Chromosomal translocation of 5q and 7q</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">12q21 deletion: 1 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">12q21 deletion: with interstitial deletion of chromosome 12. Breakpoints at bands 12q21.2 and 12q22. This results in partial monosomy for 12q-&gt;12q22</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Ring chromosome 8: 2 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">Deletion of 11.99 Mb of DNA from 18p11.21pter and 448.2 kb of DNA from 18q23qter; duplication of genetic material from 18q23q23; duplication of 1.44 Mb of DNA from 6p25.1p24.3.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">8p12q11.21 deletion: 18 Mb and containing 52 genes; mosaicism for a variable number of ring 8 chromosomes.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">16p micro array aberration(s) 5 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">16p.13.3 deletion: includes part of the RBFOX1 (A2BP1) gene</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">16p13.2 deletion: including the USP7 gene</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">16p13.12p13.11. duplication</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">16p13.11 deletion: Region contains the PDXC1 and NTAN1 genes</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">16p13.3 deletion region and duplication of 15q24.2q26.3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Partial trisomy 3q/monosomy 18p: 1 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">46,XY, der(18)t(3;18). Effectively, this is a partial Trisomy 3q and partial monosomy 18p</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">15q13.3. deletion: 1 Total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">15q13.3 microdeletion syndrome. Deletion involves SZT2: c.5235_5236del(p.H1745fs)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Chromosome 2 deletion: 1 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">3.5 MB deletion of chromosome 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">1q21.1 deletion: 1 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">Deletion on chromosome 1q21.1 that spans at least 384 Kb.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">1p36.12 duplication: 1 total</td>
<td align="center" colspan="1" rowspan="1">M</td>
<td align="left" colspan="1" rowspan="1">Duplication at 1p36.12 of unknown significance</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Chromosome 2 deletion, 15q duplication: 1 total</td>
<td align="center" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">Unknown</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>In the total cohort, 140/377 patients (37%) did not have a syndromic diagnosis but had systemic involvement in one or more organ systems. When statistically analyzed by age of presentation (early/group A or late/group B), the incidence of systemic involvement was significantly higher in the late onset group: 38% in Group A versus 60% in Group B (<italic>P</italic> &lt; 0.001). Of the 188 patients with systemic and or syndromic diagnoses, 134/188 had central nervous system anomalies (71%). Looking specifically at these 134 patients, 4% had tethered cord, 11% had hydrocephalus or raised intracranial pressure, 28% had seizures/epilepsy, and 37% had developmental delay. If we look at the entire cohort of ISS patients (n = 377), 4% had raised intracranial pressure or hydrocephalus, 10% had seizures, and 13% had developmental delay. Sixty-one of 377 (16%) patients were diagnosed with other craniofacial anomalies, including cleft palate (9%), torticollis (2%), macrocephaly (4%), microcephaly (1%), and Pierre Robin sequence (1%).</p>
<p>Limb anomalies were identified in 7 patients (1.8%). Urogenital abnormalities were identified in 10 patients (2.6%). We identified 8 patients with a diagnosis of ISS and a clinical diagnosis of RASopathy (Table <xref ref-type="table" rid="T2">2</xref>): 6 diagnosed with Noonan syndrome and 2 with cardiofaciocutaneous syndrome (CFC). Five of these patients had molecular confirmation (3 Noonan 2 CFC). We describe 3 patients with metabolic disorders (Table <xref ref-type="table" rid="T2">2</xref>), 2 of whom had Rickets. Four patients tested positive for single-gene mutations. Fifteen patients with chromosomal abnormalities were identified (Table <xref ref-type="table" rid="T1">1</xref>). Three of the 15 (20%) patients identified with chromosomal abnormalities had chromosomal aberrations previously reported in patients with CS. Twenty of 377 patients (5%) with autism spectrum disorder (ASD): 16 with Autism, and 4 with Asperger’s.</p>
<table-wrap id="T2" position="float">
<label>Table 2.</label>
<caption>
<p>Systemic Findings</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Systemic Finding</th>
<th align="center" colspan="1" rowspan="1">Includes</th>
<th align="center" colspan="1" rowspan="1">Total Affected</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Seizures</td>
<td align="left" colspan="1" rowspan="1">Febrile and afebrile</td>
<td align="center" colspan="1" rowspan="1">38 (10%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cardiac abnormalities</td>
<td align="left" colspan="1" rowspan="1">ASD, VSD, PFO, PDA, murmur, arteriovenous malformation, aortic stenosis, trileaflet valve, coarctation of aorta</td>
<td align="center" colspan="1" rowspan="1">31 (8%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Renal/urogenital abnormalities</td>
<td align="left" colspan="1" rowspan="1">Renal aplasia, horshoe kidney cryptorchidism, hypospadias</td>
<td align="center" colspan="1" rowspan="1">19 (5%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Structural neurological abnormalities</td>
<td align="left" colspan="1" rowspan="1">Tethered cord, hydrocephalus</td>
<td align="center" colspan="1" rowspan="1">20 (5%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Developmental delay</td>
<td align="left" colspan="1" rowspan="1">Speech, global, cognitive</td>
<td align="center" colspan="1" rowspan="1">50 (13%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Autism spectrum disorder</td>
<td align="left" colspan="1" rowspan="1">Autism, aspergers</td>
<td align="center" colspan="1" rowspan="1">20 (5%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cleft palate</td>
<td align="left" colspan="1" rowspan="1">Submucous cleft palate</td>
<td align="center" colspan="1" rowspan="1">35 (9%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Constitutional</td>
<td align="left" colspan="1" rowspan="1">Micro/macrocephaly, Pierre Robin sequence, failure to thrive, short stature</td>
<td align="center" colspan="1" rowspan="1">35 (9%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Musculoskeletal/limb abnormalities</td>
<td align="left" colspan="1" rowspan="1">Polydactyly, syndactyly, torticollis, clubfeet</td>
<td align="center" colspan="1" rowspan="1">15 (4%)</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec sec-type="discussion">
<title>DISCUSSION</title>
<p>Single case reports and/or small case series<sup><xref ref-type="bibr" rid="R10">10</xref>,<xref ref-type="bibr" rid="R11">11</xref>,<xref ref-type="bibr" rid="R15">15</xref>,<xref ref-type="bibr" rid="R17">17</xref>–<xref ref-type="bibr" rid="R21">21</xref></sup> have reported associations between ISS and the syndromes listed in Table <xref ref-type="table" rid="T3">3</xref>. Specifically, our cohort contained Turner syndrome (n = 1), craniofrontonasal dysplasia (n = 1), rickets (n = 3), RASopathy (Noonan and CFC syndromes), (n = 8), osteogenesis imperfecta (n = 1), ectodermal dysplasia (n = 1), and Loeyz-Dietz (n = 1). We did not identify patients diagnosed with several of the syndromes previously reported in association with ISS (Table <xref ref-type="table" rid="T3">3</xref>). However, we describe ISS in association with conditions <italic>not</italic> previously described in the literature (Table <xref ref-type="table" rid="T3">3</xref>), including stickler syndrome (n = 1).</p>
<table-wrap id="T3" position="float">
<label>Table 3.</label>
<caption>
<p>Syndromes Associated with ISS, Previously Reported, and Unreported</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="2" rowspan="1">Previously Reported Syndromes Appearing in Patients with ISS</th>
<th align="center" colspan="1" rowspan="2">Previously Unreported Syndromes Found in Our ISS Cohort</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Syndromes Appearing in Our Cohort</th>
<th align="center" colspan="1" rowspan="1">Syndromes Appearing Outside Our Cohort</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Turner syndrome</td>
<td align="left" colspan="1" rowspan="1">Crouzon’s syndrome</td>
<td align="left" colspan="1" rowspan="1">Stickler syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Craniofrontonasal dysplasia</td>
<td align="left" colspan="1" rowspan="1">Frank-ter Haar syndrome</td>
<td align="left" colspan="1" rowspan="1">Kleefestra</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Rickets</td>
<td align="left" colspan="1" rowspan="1">Ellis-van Creveld syndrome</td>
<td align="left" colspan="1" rowspan="1">Waardenburg</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Noonan</td>
<td align="left" colspan="1" rowspan="1">Sensenbrenner</td>
<td align="left" colspan="1" rowspan="1">Cohen syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Osteogenesis imperfecta</td>
<td align="left" colspan="1" rowspan="1">Pfeiffer-type Cardiocranial syndrome</td>
<td align="left" colspan="1" rowspan="1">Acrocallosal syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ectodermal dysplasia</td>
<td align="left" colspan="1" rowspan="1">Carpenter syndrome</td>
<td align="left" colspan="1" rowspan="1">Linear Sebaceous Nevus syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Turner syndrome</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Pfeiffer syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Loeys-Dietz syndrome</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">DiGeorge syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cardiofaciocutaneous syndrome</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table>
</table-wrap>
<p>ISS is seldom included as a presenting feature of single gene CS syndromes—like Apert and Crouzon—but has been linked to chromosomal aberrations.<sup><xref ref-type="bibr" rid="R22">22</xref></sup> However, we identified 3 patients diagnosed with ISS and craniofacial syndromes: Pfeiffer (n = 1), Craniofrontonasal Dysplasia (n = 1), and Saethre-Chotzen (n = 1).</p>
<p>Sagittal synostosis and RASopathy, particularly Noonan syndrome, have been reported together previously, in association with the following genes: <italic>SHOC-2</italic>, <italic>KRAS</italic>, <italic>BRAF</italic>, and <italic>PTPN</italic>.<sup><xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R23">23</xref>–<xref ref-type="bibr" rid="R25">25</xref></sup> CFC has also been previously reported in patients with ISS.<sup><xref ref-type="bibr" rid="R24">24</xref></sup> Both of our patients diagnosed with CFC had mutations in BRAF. Three of 6 patients in our cohort who were clinically diagnosed with Noonan syndrome had mutations in <italic>KRAS</italic>, <italic>BRAF</italic>, and <italic>PTPN</italic> respectively, the 3 remaining patients did not reveal any mutations, but the panel used did not analyze <italic>SHOC-2</italic>. We recommend that patients with a Noonan-like phenotype undergo a RASopathy panel, inclusive of the <italic>SHOC-2</italic> gene and or whole exome sequencing.</p>
<p>Rickets has been described in association with CS previously.<sup><xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R21">21</xref></sup> We identified a single patient with ectodermal dysplasia, which has previously been reported with ISS.<sup><xref ref-type="bibr" rid="R13">13</xref></sup> Given that more than half of patients reported in Lin’s study diagnosed with ectodermal dysplasia also had ISS, there is likely a causative relationship, though the exact nature is unclear.</p>
<sec>
<title>Single Gene Mutations</title>
<p>Of the patients with single gene mutations, 1 presented with epilepsy, Chiari I malformation, plagiocephaly, and microcephaly. A syndromic diagnosis was not made, but he tested positive for a <italic>KCNT1</italic> mutation, which is associated with epilepsy. Another patient was found to have a mutation in the <italic>MESP2</italic> gene, which has been implicated in spondylocostal dysostosis type 2. Our patient did not have the typical phenotype of this condition, so it may be that we are seeing a milder/different end of the spectrum of phenotype caused by the <italic>MESP2</italic> mutation. We also identified a single patient with an <italic>FLNB</italic> mutation. Though they were not found in our patient, mutations in the <italic>FLNB</italic> gene may cause severe bone dysplasias.<sup><xref ref-type="bibr" rid="R28">28</xref></sup> Missense mutations in this gene are also associated with Larsen syndrome and Boomerang Dysplasia, a lethal form of osteochondrodysplasia.<sup><xref ref-type="bibr" rid="R29">29</xref>,<xref ref-type="bibr" rid="R30">30</xref></sup></p>
</sec>
<sec>
<title>Chromosomal Abnormalities</title>
<p>Three of the 15 (20%) patients identified with chromosomal abnormalities had chromosomal aberrations previously reported in patients with CS: Kleefestra,<sup><xref ref-type="bibr" rid="R30">30</xref></sup> 45,X (Turner syndrome)<sup><xref ref-type="bibr" rid="R20">20</xref></sup> and 22q deletion (DiGeorge Syndrome),<sup><xref ref-type="bibr" rid="R32">32</xref>,<xref ref-type="bibr" rid="R33">33</xref></sup> of which only 45,X has been reported in a patient with ISS (6%). We identified several noteworthy anomalies which so far have not been described in patients with only ISS, such as a 1p36.12 duplication, which to date is of unknown significance. However, <italic>deletions</italic> of the same region of chromosome 1p36 constitute a deletion syndrome. It is associated with developmental delay, short stature, prominent forehead, congenital heart disease, hypotonia, and early death.<sup><xref ref-type="bibr" rid="R34">34</xref>,<xref ref-type="bibr" rid="R35">35</xref></sup> Another patient had a 1q21.1 deletion, which is also associated with developmental delay, schizophrenia, microcephaly, cardiac abnormalities, and cataracts.<sup><xref ref-type="bibr" rid="R35">35</xref>–<xref ref-type="bibr" rid="R37">37</xref></sup> Another patient presented with a de novo microdeletion in 16p13.1, spanning the <italic>NTAN</italic> and <italic>NDE1 genes</italic>. Developmental delay, epilepsy, short stature, dysmorphic appearance, and behavioral problems are known to accompany this mutation. This disease has been clinically and molecularly diagnosed in fewer than 15 patients worldwide.<sup><xref ref-type="bibr" rid="R38">38</xref></sup> We also identified 2 patients with 16p13.2 deletions.<sup><xref ref-type="bibr" rid="R39">39</xref>,<xref ref-type="bibr" rid="R40">40</xref></sup> One case report describes a patient with 16p13.2 and Pfeiffer syndrome <italic>without</italic> a diagnosis of CS.<sup><xref ref-type="bibr" rid="R16">16</xref></sup> We have identified a patient with the same mutation, diagnosed with ISS, but not Pfeiffer syndrome. In total, our cohort contains 5 patients with 16p aberration(s) on microarrays. The fact that only 6% of the chromosomal aberrations described in our study have been previously reported in patients with ISS supports increased karyotyping and utilization of molecular cytogenetics in patients diagnosed with ISS who have systemic involvement.</p>
</sec>
<sec>
<title>Systemic Findings</title>
<p>In our cohort, 38/377 (10%) ISS patients had seizures. Eighteen percent of these seizure were febrile. The association between CS and seizures has been previously described.<sup><xref ref-type="bibr" rid="R26">26</xref>,<xref ref-type="bibr" rid="R27">27</xref></sup> However—to the best of our knowledge—this is the first report suggesting that 1/10 patients with ISS will suffer from seizure activity. Our cohort contains 20 patients with ASD: 16 with Autism, and 4 with Asperger’s. ASD has previously been described in patients with CS, and may be due to genetic, epigenetic, and environmental factors.<sup><xref ref-type="bibr" rid="R42">42</xref></sup> Autism is associated with both sporadic mutations and syndromes like Fragile X and 22q11.2 deletion syndrome.<sup><xref ref-type="bibr" rid="R42">42</xref>–<xref ref-type="bibr" rid="R44">44</xref></sup> Of the 20 patients identified with ASD, 4 had an additional syndromic diagnosis: CFC, 15q13.3.deletion, 16p.13.3 deletion, and congenital stationary night blindness.</p>
<p>In our cohort, the incidence of developmental delay was 13%. The association between developmental delay and CS is noted in many publications, and the incidence of neurocognitive deficits in patients with sagittal synostosis has been reported to be 3–5 times that of the unaffected population.<sup><xref ref-type="bibr" rid="R45">45</xref>–<xref ref-type="bibr" rid="R52">52</xref></sup> Developmental delay in patients with single suture CS (SSC) has been described in studies and case reports,<sup><xref ref-type="bibr" rid="R2">2</xref>,<xref ref-type="bibr" rid="R11">11</xref>,<xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R31">31</xref>,<xref ref-type="bibr" rid="R51">51</xref>–<xref ref-type="bibr" rid="R54">54</xref></sup> but there have been few studies of developmental delay in patients with ISS.<sup><xref ref-type="bibr" rid="R46">46</xref>,<xref ref-type="bibr" rid="R47">47</xref>,<xref ref-type="bibr" rid="R49">49</xref>,<xref ref-type="bibr" rid="R54">54</xref></sup> Additionally, a control-matched study of 209 patients with SSC reported that 3-year-olds with SSC scored lower on the Griffiths mental development scales than the control cohort who did not have a diagnosis of CS.<sup><xref ref-type="bibr" rid="R54">54</xref></sup> A study of operated ISS patients revealed patients with ISS and developmental delay who underwent surgical repair demonstrated a reduction in their developmental delay as evidenced by performance on the Griffiths scale.<sup><xref ref-type="bibr" rid="R54">54</xref></sup> But this is controversial.<sup><xref ref-type="bibr" rid="R50">50</xref></sup> In the ISS population, developmental delay in language and speech are frequently reported.<sup><xref ref-type="bibr" rid="R47">47</xref>,<xref ref-type="bibr" rid="R52">52</xref></sup> In our cohort, 16 of the 50 patients diagnosed with developmental delay were also diagnosed with speech delay. Abnormal speech and language development have been reported in 1/1.7 of patients with nonsyndromic SSC, and as high as 37% in metopic-sagittal synostosis patients.<sup><xref ref-type="bibr" rid="R52">52</xref></sup> Visual deficits have also been reported. Abnormalities in fixation shift have been reported in patients with ISS. One study inclusive of 15 patients with sagittal synostosis, reports 11/15 patients (73%) with ISS demonstrated abnormal fixation shift.<sup><xref ref-type="bibr" rid="R55">55</xref></sup> Like developmental delay, visual function has been shown to improve postoperatively in patients with CS. In particular, patients with sagittal CS demonstrated a deficit in gross locomotor function which resolved after surgical correction of deformity.<sup><xref ref-type="bibr" rid="R54">54</xref></sup> We recommend patients with ISS undergo full pediatric and ophthalmic evaluations in addition to their craniofacial assessment, considering that surgical intervention has been shown to ameliorate visual, cognitive, or developmental delays.<sup><xref ref-type="bibr" rid="R54">54</xref></sup></p>
<p>To the best of our knowledge, this is the largest series investigating the incidence of syndromes/systemic involvement in patients with ISS. We report 188/377 patients with systemic involvement, and 13% of the total cohort had a syndromic diagnosis. The proportion of ISS patients who underwent testing was small (20%), but the pediatric patient registry uncovered a large proportion of syndromes and genetic mutations underlying their sagittal synostosis diagnosis. Even though ISS is the most common form of CS, physicians and scientists have not yet identified a genetic cause for most forms of ISS. On the other hand, syndromic forms of CS—though less common—are known to be caused by &gt;60 associated genetic mutations.<sup><xref ref-type="bibr" rid="R56">56</xref></sup> Since genetic testing has resulted in the discovery of novel mutations related to ISS etiology,<sup><xref ref-type="bibr" rid="R10">10</xref>–<xref ref-type="bibr" rid="R12">12</xref>,<xref ref-type="bibr" rid="R18">18</xref>,<sup><xref ref-type="bibr" rid="R24">24</xref></sup>,<sup><xref ref-type="bibr" rid="R25">25</xref></sup>,<sup><xref ref-type="bibr" rid="R34">34</xref></sup>,<sup><xref ref-type="bibr" rid="R57">57</xref></sup></sup> we suspect that increased genetic testing of these patients may result in better knowledge regarding the etiology of ISS.</p>
</sec>
</sec>
<sec sec-type="conclusions">
<title>CONCLUSIONS</title>
<p>We suggest that our finding that almost half of patients with ISS have some sort of systemic involvement warrants that children diagnosed with ISS undergo complete pediatric and evaluations with appropriate utilization of molecular cytogenetics of array-CGH as well as molecular testing for pathogenic variants in the genes by single gene, gene panel, or whole exome sequencing. A statistically significant higher incidence of systemic involvement was found in the late onset ISS subgroup, which supports long-term monitoring of patients with early and late onset ISS. Many children with ISS are followed by a primary care pediatrician. Craniofacial surgeons, and other providers, should be aware that a significant proportion of patients with ISS may have syndromic or systemic involvement. Such knowledge may result in better treatment strategies for these children.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="other">
<p>Published online 30 December 2019.</p>
</fn>
<fn fn-type="COI-statement">
<p><bold>Disclosure:</bold> The authors have no financial interest to declare in relation to the content of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>REFERENCES</title>
<ref id="R1">
<label>1.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milhorat</surname><given-names>TH</given-names></name><name><surname>Nishikawa</surname><given-names>M</given-names></name><name><surname>Kula</surname><given-names>RW</given-names></name><etal></etal></person-group>
<article-title>Mechanisms of cerebellar tonsil herniation in patients with chiari malformations as guide to clinical management.</article-title>
<source/>Acta Neurochir (Wien). <year>2010</year>;<volume>152</volume>:<fpage>1117</fpage>–<lpage>1127</lpage>.<pub-id pub-id-type="pmid">20440631</pub-id></mixed-citation>
</ref>
<ref id="R2">
<label>2.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Starr</surname><given-names>JR</given-names></name><name><surname>Collett</surname><given-names>BR</given-names></name><name><surname>Gaither</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>Multicenter study of neurodevelopment in 3-year-old children with and without single-suture craniosynostosis.</article-title>
<source/>Arch Pediatr Adolesc Med. <year>2012</year>;<volume>166</volume>:<fpage>536</fpage>–<lpage>542</lpage>.<pub-id pub-id-type="pmid">22312170</pub-id></mixed-citation>
</ref>
<ref id="R3">
<label>3.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Rocco</surname><given-names>F</given-names></name><name><surname>Arnaud</surname><given-names>E</given-names></name><name><surname>Renier</surname><given-names>D</given-names></name></person-group>
<article-title>Evolution in the frequency of nonsyndromic craniosynostosis.</article-title>
<source/>J Neurosurg Pediatr. <year>2009</year>;<volume>4</volume>:<fpage>21</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">19569905</pub-id></mixed-citation>
</ref>
<ref id="R4">
<label>4.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>D</given-names></name><name><surname>Wilkie</surname><given-names>AO</given-names></name></person-group>
<article-title>Craniosynostosis.</article-title>
<source/>Eur J Hum Genet. <year>2011</year>;<volume>19</volume>:<fpage>369</fpage>–<lpage>376</lpage>.<pub-id pub-id-type="pmid">21248745</pub-id></mixed-citation>
</ref>
<ref id="R5">
<label>5.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richtsmeier</surname><given-names>JT</given-names></name><name><surname>Grausz</surname><given-names>HM</given-names></name><name><surname>Morris</surname><given-names>GR</given-names></name><etal></etal></person-group>
<article-title>Growth of the cranial base in craniosynostosis.</article-title>
<source/>Cleft Palate Craniofac J. <year>1991</year>;<volume>28</volume>:<fpage>55</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="pmid">2004097</pub-id></mixed-citation>
</ref>
<ref id="R6">
<label>6.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aldridge</surname><given-names>K</given-names></name><name><surname>Marsh</surname><given-names>JL</given-names></name><name><surname>Govier</surname><given-names>D</given-names></name><etal></etal></person-group>
<article-title>Central nervous system phenotypes in craniosynostosis.</article-title>
<source/>J Anat. <year>2002</year>;<volume>201</volume>:<fpage>31</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="pmid">12171474</pub-id></mixed-citation>
</ref>
<ref id="R7">
<label>7.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heuzé</surname><given-names>Y</given-names></name><name><surname>Boyadjiev</surname><given-names>SA</given-names></name><name><surname>Marsh</surname><given-names>JL</given-names></name><etal></etal></person-group>
<article-title>New insights into the relationship between suture closure and craniofacial dysmorphology in sagittal nonsyndromic craniosynostosis.</article-title>
<source/>J Anat. <year>2010</year>;<volume>217</volume>:<fpage>85</fpage>–<lpage>96</lpage>.<pub-id pub-id-type="pmid">20572900</pub-id></mixed-citation>
</ref>
<ref id="R8">
<label>8.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname><given-names>AG</given-names></name><name><surname>Rudd</surname><given-names>NL</given-names></name></person-group>
<article-title>Craniosynostosis. I. Sagittal synostosis: its genetics and associated clinical findings in 214 patients who lacked involvement of the coronal suture(s).</article-title>
<source/>Teratology. <year>1976</year>;<volume>14</volume>:<fpage>185</fpage>–<lpage>193</lpage>.<pub-id pub-id-type="pmid">982314</pub-id></mixed-citation>
</ref>
<ref id="R9">
<label>9.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>VP</given-names></name><name><surname>Wall</surname><given-names>SA</given-names></name><name><surname>Lord</surname><given-names>H</given-names></name><etal></etal></person-group>
<article-title>Atypical crouzon syndrome with a novel cys62arg mutation in FGFR2 presenting with sagittal synostosis.</article-title>
<source/>Cleft Palate Craniofac J. <year>2012</year>;<volume>49</volume>:<fpage>373</fpage>–<lpage>377</lpage>.<pub-id pub-id-type="pmid">22117175</pub-id></mixed-citation>
</ref>
<ref id="R10">
<label>10.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chauhan</surname><given-names>BK</given-names></name><name><surname>Hoover</surname><given-names>JM</given-names></name><name><surname>Scanga</surname><given-names>H</given-names></name><etal></etal></person-group>
<article-title>Isolated sagittal synostosis in a boy with craniofrontonasal dysplasia and a novel EFNB1 mutation.</article-title>
<source/>Plast Reconstr Surg Glob Open. <year>2015</year>;<volume>3</volume>:<fpage>e427</fpage>.<pub-id pub-id-type="pmid">26180728</pub-id></mixed-citation>
</ref>
<ref id="R11">
<label>11.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takenouchi</surname><given-names>T</given-names></name><name><surname>Sakamoto</surname><given-names>Y</given-names></name><name><surname>Miwa</surname><given-names>T</given-names></name><etal></etal></person-group>
<article-title>Severe craniosynostosis with Noonan syndrome phenotype associated with SHOC2 mutation: clinical evidence of crosslink between FGFR and RAS signaling pathways.</article-title>
<source/>Am J Med Genet A. <year>2014</year>;<volume>164</volume>:<fpage>2869</fpage>–<lpage>2872</lpage>.</mixed-citation>
</ref>
<ref id="R12">
<label>12.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>A</given-names></name><name><surname>Weathers</surname><given-names>W</given-names></name><name><surname>Wolfswinkel</surname><given-names>E</given-names></name><etal></etal></person-group>
<article-title>Ellis–van creveld syndrome with sagittal craniosynostosis.</article-title>
<source/>Craniomaxillofac Trauma Reconstr. <year>2014</year>;<volume>08</volume>:<fpage>132</fpage>–<lpage>135</lpage>.</mixed-citation>
</ref>
<ref id="R13">
<label>13.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>AE</given-names></name><name><surname>Traum</surname><given-names>AZ</given-names></name><name><surname>Sahai</surname><given-names>I</given-names></name><etal></etal></person-group>
<article-title>Sensenbrenner syndrome (Cranioectodermal dysplasia): clinical and molecular analyses of 39 patients including two new patients.</article-title>
<source/>Am J Med Genet A. <year>2013</year>;<volume>161</volume>:<fpage>2762</fpage>–<lpage>2776</lpage>.</mixed-citation>
</ref>
<ref id="R14">
<label>14.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bendon</surname><given-names>CL</given-names></name><name><surname>Fenwick</surname><given-names>AL</given-names></name><name><surname>Hurst</surname><given-names>JA</given-names></name><etal></etal></person-group>
<article-title>Frank-ter haar syndrome associated with sagittal craniosynostosis and raised intracranial pressure.</article-title>
<source/>BMC Med Genet. <year>2012</year>;<volume>13</volume>:<fpage>104</fpage>.<pub-id pub-id-type="pmid">23140272</pub-id></mixed-citation>
</ref>
<ref id="R15">
<label>15.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phi</surname><given-names>JH</given-names></name></person-group>
<article-title>Slit ventricle syndrome and early-onset secondary craniosynostosis in an infant.</article-title>
<source/>Am J Case Rep. <year>2014</year>;<volume>15</volume>:<fpage>246</fpage>–<lpage>253</lpage>.<pub-id pub-id-type="pmid">24944727</pub-id></mixed-citation>
</ref>
<ref id="R16">
<label>16.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hufnagel</surname><given-names>RB</given-names></name><name><surname>Zimmerman</surname><given-names>SL</given-names></name><name><surname>Krueger</surname><given-names>LA</given-names></name><etal></etal></person-group>
<article-title>A new frontonasal dysplasia syndrome associated with deletion of the SIX2 gene.</article-title>
<source/>Am J Med Genet A. <year>2015</year>;<volume>170</volume>:<fpage>487</fpage>–<lpage>491</lpage>.</mixed-citation>
</ref>
<ref id="R17">
<label>17.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>MM</given-names></name><name><surname>Opitz</surname><given-names>JM</given-names></name><name><surname>Reynolds</surname><given-names>JF</given-names></name><etal></etal></person-group>
<article-title>Craniosynostosis update 1987.</article-title>
<source/>Am J Med Genet. <year>1988</year>;<volume>31</volume>:<fpage>99</fpage>–<lpage>148</lpage>.<pub-id pub-id-type="pmid">3066221</pub-id></mixed-citation>
</ref>
<ref id="R18">
<label>18.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Addissie</surname><given-names>YA</given-names></name><name><surname>Kotecha</surname><given-names>U</given-names></name><name><surname>Hart</surname><given-names>RA</given-names></name><etal></etal></person-group>
<article-title>Craniosynostosis and noonan syndrome with KRAS mutations: expanding the phenotype with a case report and review of the literature.</article-title>
<source/>Am J Med Genet A. <year>2015</year>;<volume>167</volume>:<fpage>2657</fpage>–<lpage>2663</lpage>.</mixed-citation>
</ref>
<ref id="R19">
<label>19.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>MM</given-names></name></person-group>
<article-title>Craniosynostosis in the Ullrich-Turner syndrome.</article-title>
<source/>Am J Med Genet. <year>1990</year>;<volume>35</volume>:<fpage>289</fpage>–<lpage>290</lpage>.<pub-id pub-id-type="pmid">2309772</pub-id></mixed-citation>
</ref>
<ref id="R20">
<label>20.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaszczuk</surname><given-names>P</given-names></name><name><surname>Rogers</surname><given-names>GF</given-names></name><name><surname>Guzman</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>X-linked hypophosphatemic rickets and sagittal craniosynostosis: three patients requiring operative cranial expansion: case series and literature review.</article-title>
<source/>Childs Nerv Syst. <year>2016</year>;<volume>32</volume>:<fpage>887</fpage>–<lpage>891</lpage>.<pub-id pub-id-type="pmid">26510652</pub-id></mixed-citation>
</ref>
<ref id="R21">
<label>21.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vega</surname><given-names>RA</given-names></name><name><surname>Opalak</surname><given-names>C</given-names></name><name><surname>Harshbarger</surname><given-names>RJ</given-names></name><etal></etal></person-group>
<article-title>Hypophosphatemic rickets and craniosynostosis: a multicenter case series.</article-title>
<source/>J Neurosurg Pediatr. <year>2016</year>;<volume>17</volume>:<fpage>694</fpage>–<lpage>700</lpage>.<pub-id pub-id-type="pmid">26824597</pub-id></mixed-citation>
</ref>
<ref id="R22">
<label>22.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name></person-group>
<article-title>Sagittal craniosynostosis associated with chromosome abnormalities with a brief review on craniosynostosis.</article-title>
<source/>Atlas of Genetic Diagnosis and Counseling. <year>2017</year><fpage>2523</fpage>–<lpage>2536</lpage>.</mixed-citation>
</ref>
<ref id="R23">
<label>23.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komatsuzaki</surname><given-names>S</given-names></name><name><surname>Aoki</surname><given-names>Y</given-names></name><name><surname>Niihori</surname><given-names>T</given-names></name><etal></etal></person-group>
<article-title>Mutation analysis of the SHOC2 gene in noonan-like syndrome and in hematologic malignancies.</article-title>
<source/>J Hum Genet. <year>2010</year>;<volume>55</volume>:<fpage>801</fpage>–<lpage>809</lpage>.<pub-id pub-id-type="pmid">20882035</pub-id></mixed-citation>
</ref>
<ref id="R24">
<label>24.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kratz</surname><given-names>CP</given-names></name><name><surname>Zampino</surname><given-names>G</given-names></name><name><surname>Kriek</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Craniosynostosis in patients with noonan syndrome caused by germline KRAS mutations.</article-title>
<source/>Am J Med Genet A. <year>2009</year>;<volume>149A</volume>:<fpage>1036</fpage>–<lpage>1040</lpage>.<pub-id pub-id-type="pmid">19396835</pub-id></mixed-citation>
</ref>
<ref id="R25">
<label>25.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueda</surname><given-names>K</given-names></name><name><surname>Yaoita</surname><given-names>M</given-names></name><name><surname>Niihori</surname><given-names>T</given-names></name><etal></etal></person-group>
<article-title>Craniosynostosis in patients with rasopathies: accumulating clinical evidence for expanding the phenotype.</article-title>
<source/>Am J Med Genet A. <year>2017</year>;<volume>173</volume>:<fpage>2346</fpage>–<lpage>2352</lpage>.<pub-id pub-id-type="pmid">28650561</pub-id></mixed-citation>
</ref>
<ref id="R26">
<label>26.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jazayeri</surname><given-names>MA</given-names></name><name><surname>Jensen</surname><given-names>JN</given-names></name><name><surname>Lew</surname><given-names>SM</given-names></name></person-group>
<article-title>Craniosynostosis following hemispherectomy in a 2.5-month-old boy with intractable epilepsy.</article-title>
<source/>J Neurosurg Pediatr. <year>2011</year>;<volume>8</volume>:<fpage>450</fpage>–<lpage>454</lpage>.<pub-id pub-id-type="pmid">22044367</pub-id></mixed-citation>
</ref>
<ref id="R27">
<label>27.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mccarthy</surname><given-names>JG</given-names></name><name><surname>Glasberg</surname><given-names>SB</given-names></name><name><surname>Cutting</surname><given-names>CB</given-names></name><etal></etal></person-group>
<article-title>Twenty-year experience with early surgery for craniosynostosis.</article-title>
<source/>Plast Reconstr Surg. <year>1995</year>;<volume>96</volume>:<fpage>296</fpage>–<lpage>298</lpage>.</mixed-citation>
</ref>
<ref id="R28">
<label>28.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Lian</surname><given-names>G</given-names></name><name><surname>Lenkinski</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>Filamin B mutations cause chondrocyte defects in skeletal development.</article-title>
<source/>Hum Mol Genet. <year>2007</year>;<volume>16</volume>:<fpage>1661</fpage>–<lpage>1675</lpage>.<pub-id pub-id-type="pmid">17510210</pub-id></mixed-citation>
</ref>
<ref id="R29">
<label>29.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bicknell</surname><given-names>LS</given-names></name><name><surname>Morgan</surname><given-names>T</given-names></name><name><surname>Bonafé</surname><given-names>L</given-names></name><etal></etal></person-group>
<article-title>Mutations in FLNB cause boomerang dysplasia.</article-title>
<source/>J Med Genet. <year>2005</year>;<volume>42</volume>:<fpage>e43</fpage>.<pub-id pub-id-type="pmid">15994868</pub-id></mixed-citation>
</ref>
<ref id="R30">
<label>30.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greally</surname><given-names>MT</given-names></name><name><surname>Jewett</surname><given-names>T</given-names></name><name><surname>Smith</surname><given-names>WL</given-names><suffix>Jr</suffix></name><etal></etal></person-group>
<article-title>Lethal bone dysplasia in a fetus with manifestations of atelosteogenesis I and boomerang dysplasia.</article-title>
<source/>Am J Med Genet. <year>1993</year>;<volume>47</volume>:<fpage>1086</fpage>–<lpage>1091</lpage>.<pub-id pub-id-type="pmid">8291529</pub-id></mixed-citation>
</ref>
<ref id="R31">
<label>31.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sibbesen</surname><given-names>ELC</given-names></name><name><surname>Jespersgaard</surname><given-names>C</given-names></name><name><surname>Alosi</surname><given-names>D</given-names></name><etal></etal></person-group>
<article-title>Ring chromosome 9 in a girl with developmental delay and dysmorphic features: case report and review of the literature.</article-title>
<source/>Am J Med Genet A. <year>2013</year>;<volume>161</volume>:<fpage>1447</fpage>–<lpage>1452</lpage>.</mixed-citation>
</ref>
<ref id="R32">
<label>32.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Silva</surname><given-names>D</given-names></name><name><surname>Duffty</surname><given-names>P</given-names></name><name><surname>Booth</surname><given-names>P</given-names></name><etal></etal></person-group>
<article-title>Family studies in chromosome 22q11 deletion: further demonstration of phenotypic heterogeneity.</article-title>
<source/>Clin Dysmorphol. <year>1995</year>;<volume>4</volume>:<fpage>294</fpage>–<lpage>303</lpage>.<pub-id pub-id-type="pmid">8574419</pub-id></mixed-citation>
</ref>
<ref id="R33">
<label>33.</label>
<mixed-citation publication-type="webpage"><article-title>22q11.2 deletion syndrome - Genetics Home Reference - NIH. U.S. National Library of Medicine.</article-title>
<comment><ext-link ext-link-type="uri" xlink:href="https://ghr.nlm.nih.gov/condition/22q112-deletion-syndrome">https://ghr.nlm.nih.gov/condition/22q112-deletion-syndrome</ext-link>. Accessed July 11, 2018</comment>.</mixed-citation>
</ref>
<ref id="R34">
<label>34.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiraki</surname><given-names>Y</given-names></name><name><surname>Fujita</surname><given-names>H</given-names></name><name><surname>Yamamori</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>Mild craniosynostosis with 1p36.3 trisomy and 1p36.3 deletion syndrome caused by familial translocation t(Y;1).</article-title>
<source/>Am J Med Genet A. <year>2006</year>;<volume>140</volume>:<fpage>1773</fpage>–<lpage>1777</lpage>.<pub-id pub-id-type="pmid">16835918</pub-id></mixed-citation>
</ref>
<ref id="R35">
<label>35.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heilstedt</surname><given-names>HA</given-names></name><name><surname>Ballif</surname><given-names>BC</given-names></name><name><surname>Howard</surname><given-names>LA</given-names></name><etal></etal></person-group>
<article-title>Population data suggest that deletions of 1p36 are a relatively common chromosome abnormality.</article-title>
<source/>Clin Genet. <year>2003</year>;<volume>64</volume>:<fpage>310</fpage>–<lpage>316</lpage>.<pub-id pub-id-type="pmid">12974736</pub-id></mixed-citation>
</ref>
<ref id="R36">
<label>36.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernier</surname><given-names>R</given-names></name><name><surname>Steinman</surname><given-names>KJ</given-names></name><name><surname>Reilly</surname><given-names>B</given-names></name><etal></etal></person-group>; <collab>Simons VIP consortium</collab>. <article-title>Clinical phenotype of the recurrent 1q21.1 copy-number variant.</article-title>
<source/>Genet Med. <year>2016</year>;<volume>18</volume>:<fpage>341</fpage>–<lpage>349</lpage>.<pub-id pub-id-type="pmid">26066539</pub-id></mixed-citation>
</ref>
<ref id="R37">
<label>37.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christiansen</surname><given-names>J</given-names></name><name><surname>Dyck</surname><given-names>JD</given-names></name><name><surname>Elyas</surname><given-names>BG</given-names></name><etal></etal></person-group>
<article-title>Chromosome 1q21.1 contiguous gene deletion is associated with congenital heart disease.</article-title>
<source/>Circ Res. <year>2004</year>;<volume>94</volume>:<fpage>1429</fpage>–<lpage>1435</lpage>.<pub-id pub-id-type="pmid">15117819</pub-id></mixed-citation>
</ref>
<ref id="R38">
<label>38.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockman</surname><given-names>J</given-names></name></person-group>
<article-title>Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes.</article-title>
<source/>Yearbook of Pediatrics. <year>2010</year>;<volume>2010</volume>:<fpage>300</fpage>–<lpage>302</lpage>.</mixed-citation>
</ref>
<ref id="R39">
<label>39.</label>
<mixed-citation publication-type="webpage"><collab>INSERM</collab>. <article-title>Orphanet: Syndrome de microd. Orphanet: Achromatopsia.</article-title>
<comment><ext-link ext-link-type="uri" xlink:href="https://www.orpha.net/consor4.01/www/cgi-bin/OC_Exp.php?lng=FR&amp;Expert=261236">https://www.orpha.net/consor4.01/www/cgi-bin/OC_Exp.php?lng=FR&amp;Expert=261236</ext-link>. Accessed July 11, 2018</comment>.</mixed-citation>
</ref>
<ref id="R40">
<label>40.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hempel</surname><given-names>M</given-names></name><name><surname>Brugués</surname><given-names>NR</given-names></name><name><surname>Wagenstaller</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Microdeletion syndrome 16p11.2-p12.2: clinical and molecular characterization.</article-title>
<source/>Am J Med Genet A. <year>2009</year>;<volume>149A</volume>:<fpage>2106</fpage>–<lpage>2112</lpage>.<pub-id pub-id-type="pmid">19676056</pub-id></mixed-citation>
</ref>
<ref id="R41">
<label>41.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ettinger</surname><given-names>N</given-names></name><name><surname>Williams</surname><given-names>M</given-names></name><name><surname>Phillips</surname><given-names>JA</given-names><suffix>3rd.</suffix></name></person-group>
<article-title>Variable expressivity and clinical heterogeneity can complicate the diagnosis and management of pfeiffer syndrome.</article-title>
<source/>J Craniofac Surg. <year>2013</year>;<volume>24</volume>:<fpage>1829</fpage>–<lpage>1832</lpage>.<pub-id pub-id-type="pmid">24036790</pub-id></mixed-citation>
</ref>
<ref id="R42">
<label>42.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waye</surname><given-names>MMY</given-names></name><name><surname>Cheng</surname><given-names>HY</given-names></name></person-group>
<article-title>Genetics and epigenetics of autism: a review.</article-title>
<source/>Psychiatry Clin Neurosci. <year>2018</year>;<volume>72</volume>:<fpage>228</fpage>–<lpage>244</lpage>.<pub-id pub-id-type="pmid">28941239</pub-id></mixed-citation>
</ref>
<ref id="R43">
<label>43.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>TW</given-names></name><name><surname>Berry-Kravis</surname><given-names>E</given-names></name></person-group>
<article-title>Autism and fragile X syndrome.</article-title>
<source/>Semin Neurol. <year>2014</year>;<volume>34</volume>:<fpage>258</fpage>–<lpage>265</lpage>.<pub-id pub-id-type="pmid">25192504</pub-id></mixed-citation>
</ref>
<ref id="R44">
<label>44.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenger</surname><given-names>TL</given-names></name><name><surname>Miller</surname><given-names>JS</given-names></name><name><surname>Depolo</surname><given-names>LM</given-names></name><etal></etal></person-group>
<article-title>22q11.2 duplication syndrome: elevated rate of autism spectrum disorder and need for medical screening.</article-title>
<source/>Mol Autism. <year>2016</year>;<volume>7</volume>:<fpage>27</fpage>.<pub-id pub-id-type="pmid">27158440</pub-id></mixed-citation>
</ref>
<ref id="R45">
<label>45.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartlett</surname><given-names>S</given-names></name></person-group>
<article-title>Speech, cognitive, and behavioral outcomes in nonsyndromic craniosynostosis.</article-title>
<source/>Yearbook of Plastic and Aesthetic Surgery. <year>2007</year>;<volume>2007</volume>:<fpage>26</fpage>.</mixed-citation>
</ref>
<ref id="R46">
<label>46.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shipster</surname><given-names>C</given-names></name><name><surname>Hearst</surname><given-names>D</given-names></name><name><surname>Somerville</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Speech, language, and cognitive development in children with isolated sagittal synostosis.</article-title>
<source/>Dev Med Child Neurol. <year>2002</year>;<volume>45</volume>.</mixed-citation>
</ref>
<ref id="R47">
<label>47.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virtanen</surname><given-names>R</given-names></name><name><surname>Korhonen</surname><given-names>T</given-names></name><name><surname>Fagerholm</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Neurocognitive sequelae of scaphocephaly.</article-title>
<source/>Pediatrics. <year>1999</year>;<volume>103</volume>:<fpage>791</fpage>–<lpage>795</lpage>.<pub-id pub-id-type="pmid">10103304</pub-id></mixed-citation>
</ref>
<ref id="R48">
<label>48.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Da Costa</surname><given-names>AC</given-names></name><name><surname>Anderson</surname><given-names>VA</given-names></name><name><surname>Holmes</surname><given-names>AD</given-names></name><etal></etal></person-group>
<article-title>Longitudinal study of the neurodevelopmental characteristics of treated and untreated nonsyndromic craniosynostosis in infancy.</article-title>
<source/>Childs Nerv Syst. <year>2013</year>;<volume>29</volume>:<fpage>985</fpage>–<lpage>995</lpage>.<pub-id pub-id-type="pmid">23358908</pub-id></mixed-citation>
</ref>
<ref id="R49">
<label>49.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christian</surname><given-names>E</given-names></name><name><surname>Imahiyerobo</surname><given-names>T</given-names></name><name><surname>Johns</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>310 Predictors of preoperative developmental delay in nonsyndromic sagittal craniosynostosis.</article-title>
<source/>Neurosurgery. <year>2016</year>;<volume>63</volume>:<fpage>189</fpage>.</mixed-citation>
</ref>
<ref id="R50">
<label>50.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chieffo</surname><given-names>D</given-names></name><name><surname>Tamburrini</surname><given-names>G</given-names></name><name><surname>Massimi</surname><given-names>L</given-names></name><etal></etal></person-group>
<article-title>Long-term neuropsychological development in single-suture craniosynostosis treated early.</article-title>
<source/>J Neurosurg Pediatr. <year>2010</year>;<volume>5</volume>:<fpage>232</fpage>–<lpage>237</lpage>.<pub-id pub-id-type="pmid">20192638</pub-id></mixed-citation>
</ref>
<ref id="R51">
<label>51.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speltz</surname><given-names>ML</given-names></name><name><surname>Collett</surname><given-names>BR</given-names></name><name><surname>Wallace</surname><given-names>ER</given-names></name><etal></etal></person-group>
<article-title>Intellectual and academic functioning of school-age children with single-suture craniosynostosis.</article-title>
<source/>Pediatrics. <year>2015</year>;<volume>135</volume>:<fpage>e615</fpage>–<lpage>e623</lpage>.<pub-id pub-id-type="pmid">25713274</pub-id></mixed-citation>
</ref>
<ref id="R52">
<label>52.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naran</surname><given-names>S</given-names></name><name><surname>Miller</surname><given-names>M</given-names></name><name><surname>Shakir</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>Nonsyndromic craniosynostosis and associated abnormal speech and language development.</article-title>
<source/>Plast Reconstr Surg. <year>2017</year>;<volume>140</volume>:<fpage>62e</fpage>–<lpage>69e</lpage>.</mixed-citation>
</ref>
<ref id="R53">
<label>53.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>M</given-names></name><name><surname>Quinonez</surname><given-names>S</given-names></name><name><surname>Ackley</surname><given-names>T</given-names></name><etal></etal></person-group>
<article-title>Multiple congenital anomalies and developmental delay in a boy associated with a de novo 16p13.3 deletion.</article-title>
<source/>Am J Med Genet A. <year>2011</year>;<volume>155</volume>:<fpage>612</fpage>–<lpage>617</lpage>.</mixed-citation>
</ref>
<ref id="R54">
<label>54.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellew</surname><given-names>M</given-names></name><name><surname>Liddington</surname><given-names>M</given-names></name><name><surname>Chumas</surname><given-names>P</given-names></name><etal></etal></person-group>
<article-title>Preoperative and postoperative developmental attainment in patients with sagittal synostosis: 5-year follow-up.</article-title>
<source/>J Neurosurg Pediatr. <year>2011</year>;<volume>7</volume>:<fpage>121</fpage>–<lpage>126</lpage>.<pub-id pub-id-type="pmid">21284455</pub-id></mixed-citation>
</ref>
<ref id="R55">
<label>55.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricci</surname><given-names>D</given-names></name><name><surname>Vasco</surname><given-names>G</given-names></name><name><surname>Baranello</surname><given-names>G</given-names></name><etal></etal></person-group>
<article-title>Visual function in infants with non-syndromic craniosynostosis.</article-title>
<source/>Dev Med Child Neurol. <year>2007</year>;<volume>49</volume>:<fpage>574</fpage>–<lpage>576</lpage>.<pub-id pub-id-type="pmid">17635200</pub-id></mixed-citation>
</ref>
<ref id="R56">
<label>56.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agochukwu</surname><given-names>NB</given-names></name><name><surname>Solomon</surname><given-names>BD</given-names></name><name><surname>Muenke</surname><given-names>M</given-names></name></person-group>
<article-title>Impact of genetics on the diagnosis and clinical management of syndromic craniosynostoses.</article-title>
<source/>Childs Nerv Syst. <year>2012</year>;<volume>28</volume>:<fpage>1447</fpage>–<lpage>1463</lpage>.<pub-id pub-id-type="pmid">22872262</pub-id></mixed-citation>
</ref>
<ref id="R57">
<label>57.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lattanzi</surname><given-names>W</given-names></name><name><surname>Bukvic</surname><given-names>N</given-names></name><name><surname>Barba</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Genetic basis of single-suture synostoses: genes, chromosomes and clinical implications.</article-title>
<source/>Childs Nerv Syst. <year>2012</year>;<volume>28</volume>:<fpage>1301</fpage>–<lpage>1310</lpage>.<pub-id pub-id-type="pmid">22872241</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>